Consolidated Statements of Cash Flows - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss		$ (36,266)	$ (51,013)
Adjustments to reconcile net loss to net cash used in operating activities:
(Gain) loss on sale of businesses	[1]	(32,211)	582
Depreciation and amortization	[1]	12,602	17,543
Amortization of debt discounts and deferred financing offering cost	[1]	4,779	4,207
Impairment of goodwill and other intangible assets	[1]	0	3,977
Change in fair value of derivatives liability	[1]	7	0
Change in fair value of Bookings Commitment	[1]	3,070	4,664
Stock-based compensation	[1]	1,684	1,849
Deferred income taxes, net	[1]	(181)	(549)
Provision for bad debt expense	[1]	118	17
Loss from related party equity method investment	[1]	31,702	6,401
Changes in operating assets and liabilities:
Accounts receivable, net	[1]	3,879	3,202
Inventories	[1]	(18)	294
Related party receivables, net	[1]	(258)	542
Prepaid expenses and other current assets	[1]	14,493	(19,986)
Deferred implementation costs	[1]	0	14
Accounts payable	[1]	(1,671)	1,259
Accrued and other current liabilities	[1]	(17,881)	20,096
Deferred revenue	[1]	(4,944)	(2,411)
Related party payables, net	[1]	5,416	3,766
Change in operating lease right-of-use assets and liabilities	[1]	(228)	(297)
Other assets and liabilities	[1]	(77)	(605)
Net cash used in operating activities	[1]	(15,985)	(6,448)
Cash flows from investing activities:
Net proceeds from sale of businesses	[1]	46,401	300
Assignment of OpenNMS, net of cash acquired (see Note 19)	[1]	(5,475)	0
Purchases of property and equipment, including internal-use software	[1]	(4,281)	(3,495)
Net cash provided by (used in) investing activities	[1]	36,645	(3,195)
Cash flows from financing activities:
Proceeds from insurance promissory note	[1]	1,855	1,647
Repayments of insurance promissory note and notes payable	[1]	(1,045)	(701)
Proceeds from exercises of stock options	[1]	171	0
Tax payments related to stock issued, net of stock withheld, for vested equity awards	[1]	(739)	(270)
Net cash provided by financing activities	[1]	242	676
Effect of exchange rate changes on cash, cash equivalents and restricted cash	[1]	2	(12)
Net increase (decrease) in cash, cash equivalents and restricted cash	[1]	20,904	(8,979)
Cash, cash equivalents and restricted cash, beginning of period	[1],[2]	6,379	19,441
Cash, cash equivalents and restricted cash, end of period	[1],[2]	27,283	10,462
Supplemental disclosure of cash flow information:
Income taxes paid		151	3
Interest paid		2,961	2,958
Noncash investing and financing activities:
Purchases of property and equipment including internal use software		$ 297	$ 105

[1] The statements for the nine months ended September 30, 2020 and 2019 include the Connected Care Business (see Note 4).

[2] Cash and cash equivalents included restricted cash of $1,136 and $1,375 at December 31, 2019 and September 30, 2020, respectively, and $1,136 and $1,136 at December 31, 2018 and September 30, 2019, respectively. Restricted cash is included in other assets and consists of funds that are contractually restricted as to usage or withdrawal related to the Company's security deposits in the form of standby letters of credit for leased facilities and funds held in an escrow account related to the sale of the Connected Care Business (see Note 4). No amounts have been drawn upon the letters of credit as of September 30, 2020.